Contact

Liminal Root Home About Services Clinic Guide Safety & Risks Veteran Resources Contact Independent context for complex choices Ibogaine Treatment Mexico A calm, evidence-aware overview of ibogaine care pathways in Mexico, including safety, regulation, research, and decision-making. Information resource, not a treatment provider Starting with the basics What the term describes Ibogaine treatment in Mexico generally refers to clinic-based, medically supervised use of ibogaine for addiction and trauma-related concerns within a permissive but unregulated setting. 01 / Substance Ibogaine Ibogaine is a naturally occurring indole alkaloid extracted from the root bark of Tabernanthe iboga , a plant with traditions in Central and West African ceremonial contexts. The broader ibogaine record includes its psychoactive effects and continuing therapeutic investigation. 02 / Care model Short-course care It is commonly described as a single- or short-course “addiction interrupter,” rather than a daily maintenance drug, and may involve an extended, dreamlike psychological experience. 03 / Scope Why Mexico People travel for care related to opioid, stimulant, alcohol, and polysubstance use, as well as PTSD, depression, anxiety, traumatic brain injury, and other trauma-related conditions. Regulation is not quality assurance A legal gray area, not a uniform system In the United States, ibogaine remains a Schedule I controlled substance and clinical use is prohibited. The DEA scheduling framework is one reason U.S. patients continue to look beyond the border. In Mexico, ibogaine is not scheduled under federal law. That has enabled clinics to operate openly, often inside or adjacent to hospitals, but it does not create a single, standardized framework for clinical practice. A practical overview of treatment availability in Mexico can help illustrate why clinic conditions require individual scrutiny. People considering travel may encounter different claims, protocols, and standards. T

Contact

Published channels